Indivior Pharmaceuticals INDV
NASDAQ INDV
$38.19 -0.85 (-2.18%)
At close: Aug 20, 2026 · 1:46 PM UTC

Indivior Pharmaceuticals (INDV) EBT Margin (2024 - 2026)

Indivior Pharmaceuticals (INDV) posted quarterly EBT Margin of 36.28% for Q1 2026, up 1410.0% year-over-year from 2.4% in Q1 2025, and up 60.34% quarter-over-quarter from 22.63% in Q4 2025.

Indivior Pharmaceuticals (INDV) EBT Margin (2024 - 2026) Analysis & Trends

Indivior Pharmaceuticals' EBT Margin history runs 3 years deep, the most recent figure standing at 36.28% for Q1 2026.

  • In Q1 2026, EBT Margin rose 1410.0% year-over-year to 36.28%; the TTM figure through Mar 2026 stood at 22.85% (up 2234.0% YoY), while the FY2025 annual figure was 19.29%, up 1761.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 36.28%, up from 22.63% in the prior quarter.
  • The five-year high for EBT Margin was 36.28% in Q1 2026, with the low at 40.47% in Q2 2024.
  • The 3-year median for EBT Margin is 20.53% (2025), against an average of 13.46%.
  • Peak annual rise in EBT Margin reached 6100 bps in 2025, while the deepest fall reached 352 bps in 2025.
  • Indivior Pharmaceuticals' EBT Margin stood at 12.71% in 2024, then jumped by 78 bps to 22.63% in 2025, then surged by 60 bps to 36.28% in 2026.
  • Business Quant data shows INDV's EBT Margin at 36.28% in Q1 2026, 22.63% in Q4 2025, and 11.78% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -10.99%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 47.58%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Indivior Pharmaceuticals 4.54 Bn 4.32 Bn 294.00 Mn 46.65%

Historic Data

Download Data
DateValue
Jun 30, 2026 46.65%
Mar 31, 2026 36.28%
Dec 31, 2025 22.63%
Sep 30, 2025 11.78%
Jun 30, 2025 20.53%
Mar 31, 2025 22.18%
Dec 31, 2024 12.71%
Sep 30, 2024 9.77%
Jun 30, 2024 -40.47%
Mar 31, 2024 25.70%